Medicare utilization — ARTHUR KOROTKIN (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,660 | 57 | $0 | $541,192 |
| J0178 | Injection, aflibercept, 1 mg | 3,268 | 350 | $0 | $2,245,743 |
| 92134 | Imaging of retina | 3,140 | 935 | $0 | $102,534 |
| 67028 | Injection of drug into eye | 2,658 | 558 | $0 | $276,640 |
| J7999 | Compounded drug, not otherwise classified | 1,173 | 349 | $0 | $89,227 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·